Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Dr. John Prensner, M.D., Ph.D. – The Regents of the University of Michigan, Ann Arbor, MI
Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Dr. Gunda Georg, Ph.D. – Regents of the University of Minnesota - Twin Cities, Minneapolis, MN
Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dr. Yuan Gao, Ph.D. – Case Western Reserve University - School of Medicine, Cleveland, OH
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Case Western Reserve University - School of Medicine, Cleveland, OH